Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation

OnabotulinumtoxinA is being increasingly used in the management of chronic migraine (CM). Treatment with onabotulinumtoxinA poses challenges compared with traditional therapy with orally administered preventatives. The European Headache Federation identified an expert group that was asked to develop...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Headache Pain
Prif Awduron: Bendtsen, Lars, Sacco, Simona, Ashina, Messoud, Mitsikostas, Dimos, Ahmed, Fayyaz, Pozo-Rosich, Patricia, Martelletti, Paolo
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer Milan 2018
Pynciau:
Consensus Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6755553/
https://ncbi.nlm.nih.gov/pubmed/30259200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10194-018-0921-8
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg